LEXICON PHARMACEUTICALS, INC. Payments for Postemployment Benefits
LEXICON PHARMACEUTICALS, INC. (LXRX) reported Payments for Postemployment Benefits of $3.70 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-07.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsForPostemploymentBenefits · last filed 2025-03-07
- LEXICON PHARMACEUTICALS, INC. payments for postemployment benefits for the quarter ending 2024-12-31 was $1.80M.
- LEXICON PHARMACEUTICALS, INC. payments for postemployment benefits for fiscal 2024 was $3.70M.
| Period end | Payments for Postemployment Benefits 3 month | Payments for Postemployment Benefits 9 month | Payments for Postemployment Benefits 12 month |
|---|---|---|---|
| 2024-12-31 | $1.80M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | $3.70M 10-K · filed 2025-03-07 | |
| 2024-09-30 | $1.90M 10-Q · filed 2024-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |